"Treating complex pain conditions requires complex treatment strategies. By stimulating areas of the brain, with non invasive sound, the BAUD unit is a great adjunctive treatment."

John Garzione, PT, DPT, DAAPM, Chenango Therapeutics

"I have used it successfully with a client who has ongoing pain issues due to an inoperable benign mengioma, and the results have been impressive."

L.M. PhD, Omaha, NE

BAUD Shows Promise
as Adjunct In Chronic
Pain Management

The Bio-Acoustical Utilization Device (BAUD), a biofeedback device, has shown promise in the management of patients with central sensitization.

Read more here.


A New View of Chronic Pain

Relief is elusive for tens of millions in the US today who suffer from chronic pain. Current therapies have drawbacks, including the risk of dependency or addiction. Fortunately, neuroscience is offering new approaches to chronic pain. Emerging research is revealing chronic pain as a maladaptive plasticity of pain circuits in the brain. Over time, neural circuits in the brain become sensitized to continuous pain signals, and begin to register pain constantly at inappropriately high levels - central sensitization occurs. This type of chronic pain can persist long after physical problems have healed.

The Promise of Targeted Plasticity

New non-invasive therapies based on stimulating the brain's inherent neuroplasticity are emerging, with the more promising developments based on modulating activity in the limbic system. The amygdala and limbic system play a central role in both the creation of chronic pain and the modulation of pain inhibition.

The BAUD is a novel method for promoting deep, targeted relaxation, which research shows can help promote natural brain plasticity. Using a specific type of sounds and beats, the BAUD will help your patient release the stress that activates and drives many negative habit patterns and reactions. As a result, it becomes easier for them to reshape reactive patterns of thought, feeling and action, and to quiet those negative symptoms.

BAUD Case Study: Severe Pain from Guillain Barré Syndrome

Claus is a 70 year-old Swedish man who suffered an attack of Guillain Barré Syndrome at age 55. Completely paralyzed for days, he eventually recovered most motor function, but was left with paralysis and severe nerve pain in the lower limbs (SUD 7-9 daily). He utilized oxycontin daily, morphine several times per week, and was hospitalized several times a year for monitoring of high-dose morphine to bring pain levels down. This was his life for 15 years. BAUD results: after adding the BAUD to his normal therapy sessions, Claus was able to go off his pain medications. He reports his pain level is down to 0-2 SUD daily. After 2 years, he remains nearly pain-free and still requires no pain medication.



 
 
The BAUD is FDA cleared as a class II adjunct therapy, and carries no significant negative side effects.